The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Presentation information

Print

Poster Presentation

(C) Pharmaceutical Biology

[28PO9-am2] Central nervous system (Diseases and therapies)-2

Mon. Mar 28, 2022 10:50 AM - 12:30 PM [Room PO9] Lounge in front of Room B (Bldg. 1: 3F)

10:50 AM - 12:30 PM

[28PO9-am2-10] PERK inhibitor GSK2606414 has protective effects in in vitro Parkinson’s disease through ER stress independent pathways.

○Yasuhiro Noda1, Tadashi Nakagawa1, Toru Hosoi1 (1. Pharm. Sci., Sanyo-Onoda City Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password